ARTICLE | Company News
Microlin Bio, American Boarding deal
January 4, 2016 8:00 AM UTC
Microlin Bio reverse-merged with American Boarding. Microlin Bio is developing microRNA-based therapies for cancer. Its lead candidate, lumiralin ( AM-21), an anti- microRNA-21 (miR-21), is in precli...